Equity
AOCI
United Therapeutics AOCI decreased by 1233.3% to -$10.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 750.0%, from -$1.20M to -$10.20M. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a -42.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
Fluctuations often signal changes in foreign exchange rates, interest rate environments, or pension funding status.
Detailed definition
Accumulated Other Comprehensive Income (AOCI) captures the cumulative unrealized gains and losses that are excluded from...
Peer comparison
Standard equity component for large multinational corporations with complex balance sheets.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$18.60M | -$20.10M | -$23.00M | -$54.30M | -$65.50M | -$84.10M | -$55.50M | -$38.80M | -$50.60M | -$43.70M | -$12.80M | -$15.60M | -$14.90M | $7.40M | -$3.40M | -$1.20M | $0.00 | $100.00K | $900.00K | -$10.20M |
| QoQ Change | — | -8.1% | -14.4% | -136.1% | -20.6% | -28.4% | +34.0% | +30.1% | -30.4% | +13.6% | +70.7% | -21.9% | +4.5% | +149.7% | -145.9% | +64.7% | +100.0% | — | +800.0% | <-999% |
| YoY Change | — | — | — | — | -252.2% | -318.4% | -141.3% | +28.5% | +22.7% | +48.0% | +76.9% | +59.8% | +70.6% | +116.9% | +73.4% | +92.3% | +100.0% | -98.6% | +126.5% | -750.0% |
Range-$84.10M – $7.40M
CAGR-11.9%
Avg YoY Growth-46.5%
Median YoY Growth+53.9%
AOCI at Other Companies
Frequently Asked Questions
- What is United Therapeutics's aoci?
- United Therapeutics (UTHR) reported aoci of -$10.20M in Q1 2026.
- How has United Therapeutics's aoci changed year-over-year?
- United Therapeutics's aoci decreased by 750.0% year-over-year, from -$1.20M to -$10.20M.
- What is the long-term trend for United Therapeutics's aoci?
- Over 5 years (2020 to 2025), United Therapeutics's aoci has grown at a -42.4% compound annual growth rate (CAGR), from -$14.20M to $900.00K.
- What does aoci mean?
- The cumulative total of unrealized gains and losses not yet reflected in net income.